Dong-A Pharm to split into two operating entities

Published: 2012-10-25 06:59:00

Updated: 2012-10-25 06:59:00

Dong-A Pharm Co., a Korea’s largest drugmaker, said Tuesday that it will split into two operating entities to simplify its corporate structure and boost investor interest.

A board of directors finalized the plan on Tuesday, Dong-A said in a regulatory filing, and the decision will be decided a...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK